Abstract

Brugada syndrome is a primary arrhythmia syndrome characterized by loss-of-function mutations in the SCN5A gene, which encodes for the cardiac Na+ channel. In affected individuals, the risk of developing malignant ventricular arrhythmias and sudden cardiac death are increased.[1] Two leading theories, the depolarization and repolarization hypotheses, have been put forward to explain the underlying electrophysiological mechanisms[2] with the use of mouse models providing much insight into this controversial area. The monophasic action potential (MAP) recording technique has been extensively used to examine electrophysiology at the whole heart level.[3] This letter attempts to provide a brief overview to illustrate the importance of understanding the limitations of experimental methods and the need to appraise experimental data.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.